Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Minocycline Hydrochloride,Ethanol,Edetate Calcium Disodium
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Citius Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Citius Pharmaceuticals to Accelerate Phase 3 Mino-Lok Trial by Expanding Trial Sites Internationally
Details : Mino-Lok (minocycline) is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections (CRBSIs) and central line associated bloodstream infections (CLABSIs).
Product Name : Mino-Lok
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 05, 2022
Lead Product(s) : Minocycline Hydrochloride,Ethanol,Edetate Calcium Disodium
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Citius Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable